Show simple item record

AuthorMohamed Ibrahim M.I.B.
Available date2020-05-15T00:15:04Z
Publication Date2019
Publication NameEncyclopedia of Pharmacy Practice and Clinical Pharmacy
ResourceScopus
URIhttp://dx.doi.org/10.1016/B978-0-12-812735-3.00312-5
URIhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85079253063&doi=10.1016%2fB978-0-128-12735-3.00043 1&partnerID=40&md5=2de348ee80f1cb55b539a309b238e50e
URIhttp://hdl.handle.net/10576/14943
AbstractCounterfeit (falsified) medicines are dangerous and kill people. The global trade with falsified medicines is booming and it threatens the integrity of the healthcare system. The syndicates make a lot of money in this business. No country is immune from this problem. It is a crime against humanity. The matters are more problematic in countries where the regulations and punitive actions are weak, and there is lack of human and financial resources, lack of cooperation with neighboring countries, lack of capability to evaluate the medicines' quality, lack of awareness, and the extent of the problem is underestimated. This problem is very costly and should not be tolerated. Several measures need to be considered to fight against falsified medicines such as investigational measures, legal measures, security features, cooperation and networking between stakeholders and educational activities. This chapter will review briefly and discuss this issue from various viewpoints and angles. 2019 Elsevier Inc. All rights reserved.
Languageen
PublisherElsevier
SubjectAnti-counterfeiting technology
Fake drugs
Falsified medicines
Medicine quality
Patient safety
SSFFC (substandard/spurious/falsely labeled/falsified/counterfeit)
TitleCounterfeit medicines: A quick review on crime against humanity
TypeBook chapter
Pagination60-76
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record